Delivery Order SPE2DB24D1205-SPE2DB25FCTHJ

Award Date 1/24/25
Potential Completion Date 2/14/25
Potential Value $4.6K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $46,287.20 firm fixed-price contract is for the supply of VYEPTI 100 MG/ML VIALML, a medication, with a performance period ending on February 21, 2025. The contract does not have a set-aside designation, indicating open competition. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $6,943.08, is for the supply of VYEPTI 100 MG/ML VIALML, a pharmaceutical product. The contract has a firm fixed price pricing type and an ultimate completion date of March 27, 2025. The contract was awarded on March 6, 2025 and does not have a set-aside designation, indicating open...
This is a firm fixed price delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, a leading global pharmaceutical distribution company. The contract is for the supply of VYEPTI 100 MG/ML VIALML, a pharmaceutical product. The award does not have a set-aside designation. The potential value of the delivery order is $14,945.14, with a completion date of March 27, 2024. Amerisourcebergen Drug...
This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp's Corporate Office Division for the supply of the pharmaceutical product VYEPTI 100 mg/mL. The fixed-price contract, valued at $3,202.53, has an ultimate completion date of August 1, 2024. Amerisourcebergen, a major pharmaceutical distributor, leverages its extensive supply chain network to fulfill government contracts, particularly for the Department of Defense (DoD) and the...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $4,628.72, is a delivery order for the supply of VYEPTI 100 MG/ML VIALML, a medical product. This contract does not have a set-aside designation, indicating open competition. AmerisourceBergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical,...
This federal contract award is for the delivery of VYEPTI 100 MG/ML VIALML, a pharmaceutical product, to the Defense Logistics Agency (DLA). The $3,471.54 firm fixed-price delivery order was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract has an ultimate completion date of March 14, 2025 and was awarded on February 21, 2025. There is no set-aside designation indicated for this contract. Amerisourcebergen holds a...
The Defense Logistics Agency (DLA) Troop Support Medical awarded a firm fixed price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, for the provision of VYEPTI 100 MG/ML VIAL, a pharmaceutical product. The contract has a potential value of $4,270.04 and a completion date of March 12, 2024. Amerisourcebergen Drug Corp serves as the prime contractor for this delivery order, which is not associated with any set-aside designation....
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp for the supply of VYEPTI 100 MG/ML VIALML, a pharmaceutical product. The contract is a Firm Fixed Price agreement with a ceiling value of $9,607.59 and a period of performance ending on October 18, 2024. The award was made on September 26, 2024 and does not have a set-aside designation. AmerisourceBergen, a major pharmaceutical distributor, is the prime contractor for this contract,...
This is a delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, for the supply of VYEPTI 100 MG/ML VIALML, a pharmaceutical product. The firm fixed price contract, with a potential value of $3,202.53, has a completion date of February 8, 2024. The contract does not have a set-aside designation. As a prime contractor, Amerisourcebergen Drug Corp has received numerous federal contract awards...
This is a delivery order issued by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp's Corporate Office Division. The $16,012.65 fixed-price contract is for the supply of VYEPTI 100 MG/ML vials. AmerisourceBergen, a large pharmaceutical distributor, is a major supplier of medical products and medications to federal agencies through various Indefinite Delivery Contracts, including a $999,999,999 DLA contract and a $750,000 Department of Justice contract. This...
  • SPE2DB24D1205
    Indefinite Delivery Contract
  • SPE2DB24D1205-SPE2DB25FCTHJ
    Delivery Order

This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $4,628.72, is for the supply of VYEPTI 100 MG/ML VIALML, a pharmaceutical product. The contract is a firm fixed-price delivery order with an ultimate completion date of February 14, 2025. The award was made on January 24, 2025, and there is no set-aside designation indicated. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026, which serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally.

Generated 4/25/25, 10:47 AM